Springer Nature AG & Co KGaA
Springer Nature AG & Co KGaA is a German academic and scientific publishing group delivering research journals, academic books, and open-access scientific publications. The company publishes scientific research under brands including Nature, Springer, Palgrave Macmillan, and BioMed Central across medicine, technology, humanities, and sciences. Main revenue drivers comprise digital research database subscriptions, article processing charges for open-access publishing, and academic book sales. Springer Nature serves academic universities, research institutions, corporate R&D laboratories, medical scientists, and scholars globally. The company holds a market-leading global position in academic journal publishing and open-access scientific research. Headquartered in Berlin, Germany, Springer Nature AG & Co KGaA is listed on the Frankfurt Stock Exchange.
2 of the funds FundTelligence covers report a position in Springer Nature AG & Co KGaA.
- Sector
- Communication Services
- Country
- Germany
- Funds holding it
- 2
Funds holding Springer Nature AG & Co KGaA
- T. Rowe Price European Equity Fund — T. Rowe Price · 0.6 % (full portfolio disclosed, September 2026)
- JPM Europe Strategic Value Fund — JPM · 0.09 % (full portfolio disclosed, June 2026)